Second phase I trial investigating OX 27 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 21 Dec 2011
At a glance
- Drugs Sufentanil (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Pharmacokinetics
- 21 Dec 2011 Status changed from planning to completed.
- 20 Dec 2011 Results reported in an Orexo media release.
- 17 Jun 2011 New trial record